Key Points
- COO Robert Ainscow sold 8,438 shares on March 6 at an average price of $5.44 for $45,902.72, leaving him with 1,537,817 shares (a 0.55% drop in his ownership).
- ASP Isotopes (ASPI) trades around $5.80 with a 50-day/200-day moving average of $6.22/$7.65, a 52-week range of $3.71–$14.49, a market cap of $642.87M, a negative P/E (-4.46) and a beta of 3.55.
- Analysts are mixed (two Buy, one Sell) producing a consensus Hold and an average target price of $13.00, while institutional investors own about 16.8% of the stock after several recent small purchases.
ASP Isotopes Inc. (NASDAQ:ASPI - Get Free Report) COO Robert Ainscow sold 8,438 shares of the business's stock in a transaction that occurred on Friday, March 6th. The shares were sold at an average price of $5.44, for a total value of $45,902.72. Following the transaction, the chief operating officer directly owned 1,537,817 shares in the company, valued at $8,365,724.48. This trade represents a 0.55% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink.
ASP Isotopes Stock Performance
Shares of ASPI stock opened at $5.80 on Tuesday. The stock has a fifty day moving average of $6.22 and a 200 day moving average of $7.65. ASP Isotopes Inc. has a 52 week low of $3.71 and a 52 week high of $14.49. The firm has a market capitalization of $642.87 million, a price-to-earnings ratio of -4.46 and a beta of 3.55. The company has a quick ratio of 6.10, a current ratio of 6.14 and a debt-to-equity ratio of 1.04.
Wall Street Analysts Forecast Growth
Several research firms have recently commented on ASPI. Canaccord Genuity Group reaffirmed a "buy" rating and issued a $11.00 target price on shares of ASP Isotopes in a research report on Monday, November 24th. Cantor Fitzgerald initiated coverage on shares of ASP Isotopes in a research report on Thursday, December 4th. They set an "overweight" rating and a $13.00 price target on the stock. Finally, Weiss Ratings reissued a "sell (d-)" rating on shares of ASP Isotopes in a research note on Monday, December 29th. Two equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Hold" and an average target price of $13.00.
View Our Latest Stock Analysis on ASPI
Institutional Investors Weigh In On ASP Isotopes
Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Quantbot Technologies LP bought a new position in ASP Isotopes in the third quarter worth $34,000. Ameritas Investment Partners Inc. lifted its position in ASP Isotopes by 41.2% during the second quarter. Ameritas Investment Partners Inc. now owns 5,483 shares of the company's stock valued at $40,000 after buying an additional 1,600 shares during the period. BNP Paribas Financial Markets boosted its holdings in shares of ASP Isotopes by 84.9% during the 2nd quarter. BNP Paribas Financial Markets now owns 5,549 shares of the company's stock valued at $41,000 after buying an additional 2,548 shares in the last quarter. IFP Advisors Inc purchased a new stake in shares of ASP Isotopes in the 4th quarter worth about $48,000. Finally, Pictet Asset Management Holding SA purchased a new stake in shares of ASP Isotopes in the 4th quarter worth about $61,000. 16.80% of the stock is owned by hedge funds and other institutional investors.
ASP Isotopes Company Profile
(
Get Free Report)
ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
